CNS Drugs
Latest Publications

TOTAL DOCUMENTS

2485
(FIVE YEARS 284)

H-INDEX

97
(FIVE YEARS 11)

Published By Springer-Verlag

1179-1934, 1172-7047
Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

scholarly journals Comment on “Novel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status“

CNS Drugs ◽  
2022 ◽  
Author(s):  
Marco Pappagallo ◽  
Charles E. Inturrisi ◽  
Paolo L. Manfredi
Keyword(s):  
Mood Disorders ◽  
Current Status

Pharmacological Management of Apathy in Dementia

CNS Drugs ◽  
2022 ◽  
Author(s):  
Laiba Azhar ◽  
Raphael W. Kusumo ◽  
Giovanni Marotta ◽  
Krista L. Lanctôt ◽  
Nathan Herrmann
Keyword(s):  
Pharmacological Management

scholarly journals Multiple Sclerosis in Children: Differential Diagnosis, Prognosis, and Disease-Modifying Treatment

CNS Drugs ◽  
2021 ◽  
Author(s):  
Dejan Jakimovski ◽  
Samreen Awan ◽  
Svetlana P. Eckert ◽  
Osman Farooq ◽  
Bianca Weinstock-Guttman
Keyword(s):  
Multiple Sclerosis ◽  
Differential Diagnosis ◽  
Disease Modifying ◽  
Disease Modifying Treatment

scholarly journals Clinical Impact of Pitolisant on Excessive Daytime Sleepiness and Cataplexy in Adults With Narcolepsy: An Analysis of Randomized Placebo-Controlled Trials

CNS Drugs ◽  
2021 ◽  
Author(s):  
Gerard J. Meskill ◽  
Craig W. Davis ◽  
Donna Zarycranski ◽  
Markiyan Doliba ◽  
Jean-Charles Schwartz ◽  
...  
Keyword(s):  
Excessive Daytime Sleepiness ◽  
Daytime Sleepiness ◽  
Clinical Impact ◽  
Controlled Trials

Kalirin as a Novel Treatment Target for Cognitive Dysfunction in Schizophrenia

CNS Drugs ◽  
2021 ◽  
Author(s):  
Arne W. Mould ◽  
Noura Al-Juffali ◽  
Annette von Delft ◽  
Paul E. Brennan ◽  
Elizabeth M. Tunbridge
Keyword(s):  
Cognitive Dysfunction ◽  
Treatment Target ◽  
Novel Treatment
Load More ...
Sign in / Sign up

Export Citation Format

Share Document